Labshake search

3751 - 3800 of 8186 citations for 4 2 Hydroxy 1 Methoxyethyl 1 2 Benzenediol since 2020

• In vivo screening of tumor-hepatocyte interactions identifies Plexin B2 as a gatekeeper of liver metastasis

  Costanza Borrelli, et al., bioRxiv - Cancer Biology 2023

  Quote: ... BV570 anti-mouse CD45 (BioLegend #103135, 1:300) for 25 min at 4 °C ...
• Deconvolution Of Hematopoietic Stem/Progenitor Cell Signaling Predicts Inflammatory Niche Remodeling To Be A Determinant Of Tissue Failure And Outcome In Human AML

  Lanpeng Chen, et al., bioRxiv - Cancer Biology 2023

  Quote: ... CD235a-PE-Cy7(1:50, clone HI264; Biolegend), CD71-AF700 (1:20 ...
• Deconvolution Of Hematopoietic Stem/Progenitor Cell Signaling Predicts Inflammatory Niche Remodeling To Be A Determinant Of Tissue Failure And Outcome In Human AML

  Lanpeng Chen, et al., bioRxiv - Cancer Biology 2023

  Quote: ... CD3-PE-Cy7 (1:50, clone SK7; Biolegend), CD19-APC-Cy7 (1:50 ...
• Deconvolution Of Hematopoietic Stem/Progenitor Cell Signaling Predicts Inflammatory Niche Remodeling To Be A Determinant Of Tissue Failure And Outcome In Human AML

  Lanpeng Chen, et al., bioRxiv - Cancer Biology 2023

  Quote: ... CD31-APC-Cy7 (1:20, clone WM59; Biolegend), CD34-eFluor610 (1:50 ...
• Deconvolution Of Hematopoietic Stem/Progenitor Cell Signaling Predicts Inflammatory Niche Remodeling To Be A Determinant Of Tissue Failure And Outcome In Human AML

  Lanpeng Chen, et al., bioRxiv - Cancer Biology 2023

  Quote: ... CD144-PE-Cy7 (1:200, clone BV13, Biolegend), CD51-PE (1:50 ...
• Deconvolution Of Hematopoietic Stem/Progenitor Cell Signaling Predicts Inflammatory Niche Remodeling To Be A Determinant Of Tissue Failure And Outcome In Human AML

  Lanpeng Chen, et al., bioRxiv - Cancer Biology 2023

  Quote: ... Ter119-BV510 (1:50, clone TER-119, BioLegend), CD31-PE-Texas- red (1:100 ...
• Loss of IRF5 increases ribosome biogenesis leading to alterations in mammary gland architecture and metastasis

  Zarina Brune, et al., bioRxiv - Cancer Biology 2023

  Quote: CK5 (Biolegend, #905501, 1.0 mg/mL, 1:2000)
• Deconvolution Of Hematopoietic Stem/Progenitor Cell Signaling Predicts Inflammatory Niche Remodeling To Be A Determinant Of Tissue Failure And Outcome In Human AML

  Lanpeng Chen, et al., bioRxiv - Cancer Biology 2023

  Quote: ... CD19-APC-Cy7 (1:50, clone HIB19; Biolegend), CD38-FITC (1:50 ...
• Engineered probiotics limit CNS autoimmunity by stabilizing HIF-1α in dendritic cells

  Liliana M. Sanmarco, et al., bioRxiv - Immunology 2023

  Quote: ... and mouse anti-sXBP1 (Biolegend, 1:50, 647502). Secondary antibodies used in this study were ...
• Monocytes reprogrammed by 4-PBA potently contribute to the resolution of inflammation and atherosclerosis

  Shuo Geng, et al., bioRxiv - Immunology 2023

  Quote: ... anti–Ly6C (1:200 dilution, BioLegend, no. 128018), anti–ICAM-1 (1:200 dilution ...
• An Engineered 3D Co-culture Model of Primary Macrophages and Patient-Derived Tumour Cells to Explore Cellular Responses in the Graded Hypoxic Microenvironment of Pancreatic Cancer

  Ileana L. Co, et al., bioRxiv - Bioengineering 2023

  Quote: ... human anti-IFNψ (1:400; BioLegend, clone: B27), human anti-GZMB (1:400 ...
• An Engineered 3D Co-culture Model of Primary Macrophages and Patient-Derived Tumour Cells to Explore Cellular Responses in the Graded Hypoxic Microenvironment of Pancreatic Cancer

  Ileana L. Co, et al., bioRxiv - Bioengineering 2023

  Quote: ... human anti-TNFα (1:400; BioLegend, clone: Mab11), human anti-IFNψ (1:400 ...
• An Engineered 3D Co-culture Model of Primary Macrophages and Patient-Derived Tumour Cells to Explore Cellular Responses in the Graded Hypoxic Microenvironment of Pancreatic Cancer

  Ileana L. Co, et al., bioRxiv - Bioengineering 2023

  Quote: ... human anti-CD4 (1:400; BioLegend, clone: OKT4), human anti-CD8 (1:400 ...
• Immune Response of Transplanted Kidney Tissues Assembled from Organoid Building Blocks

  Thiago J. Borges, et al., bioRxiv - Bioengineering 2023

  Quote: ... CD127-PerCP-Cy5.5 (1:20, clone A019D5, Biolegend), CD16-FITC (1:40 ...
• Immune Response of Transplanted Kidney Tissues Assembled from Organoid Building Blocks

  Thiago J. Borges, et al., bioRxiv - Bioengineering 2023

  Quote: ... CD56-PE-Cy7 (1:50, clone 5.1H11, Biolegend), CD45-PE-Cy5 (1:100 ...
• Immune Response of Transplanted Kidney Tissues Assembled from Organoid Building Blocks

  Thiago J. Borges, et al., bioRxiv - Bioengineering 2023

  Quote: ... CD25-PE (1:20, clone M-A251, Biolegend), HLA-DR-APC-Cy7 (1:50 ...
• Immune Response of Transplanted Kidney Tissues Assembled from Organoid Building Blocks

  Thiago J. Borges, et al., bioRxiv - Bioengineering 2023

  Quote: ... CCR7-PE-CF594 (1:20, clone G043H7, Biolegend), CD25-PE (1:20 ...
• Immune Response of Transplanted Kidney Tissues Assembled from Organoid Building Blocks

  Thiago J. Borges, et al., bioRxiv - Bioengineering 2023

  Quote: ... CD66b-BV421 (1:50, clone 6/40c, Biolegend), CD127-PerCP-Cy5.5 (1:20 ...
• Immune Response of Transplanted Kidney Tissues Assembled from Organoid Building Blocks

  Thiago J. Borges, et al., bioRxiv - Bioengineering 2023

  Quote: ... HLA-DR-BV650 (1:50, clone L243, Biolegend), CD11c-AF700 (1:25 ...
• Immune Response of Transplanted Kidney Tissues Assembled from Organoid Building Blocks

  Thiago J. Borges, et al., bioRxiv - Bioengineering 2023

  Quote: ... CD45-PE-Cy5 (1:100, clone HI30, Biolegend), CCR7-PE-CF594 (1:20 ...
• SPATEs promote the survival of Shigella to the plasma complement system upon local hemorrhage and bacteremia

  Lorine Debande, et al., bioRxiv - Microbiology 2023

  Quote: ... 1:100 a mouse anti-human CD34 (Biolegend), 1:2000 goat anti-human complement C3 antibody (Thermo Fischer Scientific) ...
• Lactose blocks intercellular spreading of Galectin-1 from cancer cells to T-cells and activates tumor immunological control

  Yu Hong, et al., bioRxiv - Immunology 2023

  Quote: ... APC anti-mouse CD279 (PD-1) (BioLegend, 109112), FITC anti-mouse IFNγ (BioLegend ...
• Nanoparticle delivery of innate immune agonists combines with senescence-inducing agents to mediate T cell control of pancreatic cancer

  Loretah Chibaya, et al., bioRxiv - Cancer Biology 2023

  Quote: ... and CD4 PE-Cy5 (GK1.5; 1:200) (Biolegend) antibodies ...
• Selective advantage of mutant stem cells in clonal hematopoiesis occurs by attenuating the deleterious effects of inflammation and aging

  Niels Asger Jakobsen, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-CD49f-BV650 (1:40, Biolegend, clone GoH3), anti-CD117-BV785 (1:40 ...
• Selective advantage of mutant stem cells in clonal hematopoiesis occurs by attenuating the deleterious effects of inflammation and aging

  Niels Asger Jakobsen, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-CD10-BV605 (1:40, Biolegend, clone HI10a), anti-CD49f-BV650 (1:40 ...
• Selective advantage of mutant stem cells in clonal hematopoiesis occurs by attenuating the deleterious effects of inflammation and aging

  Niels Asger Jakobsen, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-CD117-BV785 (1:40, Biolegend, clone 104D2), anti-CD45RA-BB515 (1:40 ...
• The spindle protein CKAP2 regulates microtubule dynamics and ensures faithful chromosome segregation

  Lia Mara Gomes Paim, et al., bioRxiv - Cell Biology 2023

  Quote: ... rabbit polyclonal anti-TUBB3 (BioLegend, 802001, 1:200), mouse monoclonal anti-Hec1 (BioLegend ...
• FoxP3 recognizes microsatellites and bridges DNA through multimerization

  Wenxiang Zhang, et al., bioRxiv - Biochemistry 2023

  Quote: ... and Thy1.1 (Biolegend, Cat#202520, 1:1000 dilution) on day 2 post-retroviral infection ...
• Actin associates with actively elongating genes and binds directly to the Cdk9 subunit of P-TEFb

  Salla Kyheroinen, et al., bioRxiv - Cell Biology 2023

  Quote: ... Rpb1 antibody (664906, 1:500) was from BioLegend and HEXIM1 from Everest Biotech (EB06964 ...
• Syntaxin-6 delays prion protein fibril formation and prolongs presence of toxic aggregation intermediates

  Daljit Sangar, et al., bioRxiv - Biochemistry 2023

  Quote: ... 1:300) and/or anti-PrP (Biolegend (808001) clone 6D11 ...
• A brain circuit and neuronal mechanism for decoding and adapting to change in daylength

  G Maddaloni, YJ Chang, RA Senft, SM Dymecki, bioRxiv - Neuroscience 2023

  Quote: ... anti-Cre (rabbit polyclonal, 1:500, Biolegend #908001); anti-TPH2 (goat polyclonal ...
• Opposing diet, microbiome and metabolite mechanisms regulate inflammatory bowel disease in a genetically susceptible host

  Gabriel Vasconcelos Pereira, et al., bioRxiv - Microbiology 2023

  Quote: ... BV711-conjugated anti-CD3 (Biolegend, 17A2; 1/88), BV780-conjugated anti-CD45 (BD Biosciences ...
• Opposing diet, microbiome and metabolite mechanisms regulate inflammatory bowel disease in a genetically susceptible host

  Gabriel Vasconcelos Pereira, et al., bioRxiv - Microbiology 2023

  Quote: ... BV711-conjugated anti-CD3 (Biolegend, 17A2; 1/88), BV780-conjugated anti-CD45 (BD Biosciences ...
• Regulators of health and lifespan extension in genetically diverse mice on dietary restriction

  Andrea Di Francesco, et al., bioRxiv - Genetics 2023

  Quote: ... Clone RM4-5 (Cat# 100542 Biolegend (1:40)) ...
• Haptenic adducts of β-lactam antibiotics elicit antibody responses with narrow clonality and specificity

  Lachlan P. Deimel, et al., bioRxiv - Immunology 2023

  Quote: ... anti-mouse CD3-PE (1:200, 17A2, Biolegend), anti-mouse CD4-PE (1:200 ...
• Genome-wide DNA methylation changes in human spermatogenesis

  Lara M. Siebert-Kuss, et al., bioRxiv - Genetics 2023

  Quote: ... namely mIgG-AI647 (1:200, BioLegend, Cat# 400130), mIgG-Dy550 (1:20 ...
• Genome-wide DNA methylation changes in human spermatogenesis

  Lara M. Siebert-Kuss, et al., bioRxiv - Genetics 2023

  Quote: ... and mIgG-Dy488 (1:20, BioLegend Cat#400166). The remaining cells were incubated with fluorophores-conjugated primary antibodies at room temperature for 1 h against DMRT1-AI647 (1:200 ...
• Monocytes reprogrammed by 4-PBA potently contribute to the resolution of inflammation and atherosclerosis

  Shuo Geng, et al., bioRxiv - Immunology 2023

  Quote: ... anti–CD24 (1:200 dilution, BioLegend, no. 101806), and anti–ICAM-1 (1:200 dilution ...
• Monocytes reprogrammed by 4-PBA potently contribute to the resolution of inflammation and atherosclerosis

  Shuo Geng, et al., bioRxiv - Immunology 2023

  Quote: ... anti–CD16 (1:50 dilution, BioLegend, no. 360710), anti–ICAM-1 (1:50 dilution ...
• PlexinD1 deficiency in CD11c+ dendritic cells exacerbates airway hyperresponsiveness and enhances IgE and mucus production in allergic asthma

  Lianyu Shan, et al., bioRxiv - Immunology 2023

  Quote: ... and CD86-APC-Cy7 (clone GL-1; BioLegend). Subsequently ...
• The extrafollicular B cell response is a hallmark of childhood idiopathic nephrotic syndrome

  Tho-Alfakar Al-Aubodah, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human FcRL5 APC (1:20, 509f6, BioLegend), anti-human CD24 PE (1:20 ...
• The extrafollicular B cell response is a hallmark of childhood idiopathic nephrotic syndrome

  Tho-Alfakar Al-Aubodah, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD1c BV711 (1:20, L161, BioLegend), and anti-human CXCR5 APC (1:20 ...
• Lactose blocks intercellular spreading of Galectin-1 from cancer cells to T-cells and activates tumor immunological control

  Yu Hong, et al., bioRxiv - Immunology 2023

  Quote: ... PE anti-mouse CD279 (PD-1) (BioLegend, 109104), APC anti-mouse CD279 (PD-1 ...
• Glomerular immune injury promotes anti-tumor activity

  Shimrit Avraham, et al., bioRxiv - Cancer Biology 2023

  Quote: ... with TruStain FcX™ (1:100; 101320, Biolegend) and True- Stain Monocyte Blocker™ (1:20 ...
• FABP7 Progenitors are a Targetable Metabolic Root in the BRCA1 Breast

  Curtis W. McCloskey, et al., bioRxiv - Cell Biology 2023

  Quote: ... and anti-CD49f-FITC (BioLegend, 313606, 1:100). Live cells were selected based on Dapi (Sigma ...
• FABP7 Progenitors are a Targetable Metabolic Root in the BRCA1 Breast

  Curtis W. McCloskey, et al., bioRxiv - Cell Biology 2023

  Quote: ... anti-CD31-PE/Cy7 (BioLegend, 303118, 1:50), and for mammary epithelial cells subsets ...
• Selective advantage of mutant stem cells in clonal hematopoiesis occurs by attenuating the deleterious effects of inflammation and aging

  Niels Asger Jakobsen, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-CD123-PE (1:40, Biolegend, clone 6H6), anti-CD49f-PE/Dazzle594 (1:160 ...
• Selective advantage of mutant stem cells in clonal hematopoiesis occurs by attenuating the deleterious effects of inflammation and aging

  Niels Asger Jakobsen, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-CD117-BV785 (1:40, Biolegend, clone 104D2), anti-CD45RA-BB515 (1:40 ...
• Selective advantage of mutant stem cells in clonal hematopoiesis occurs by attenuating the deleterious effects of inflammation and aging

  Niels Asger Jakobsen, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-CD34-APC (1:160, Biolegend, clone 581), anti-CD2-PE/Cy5 (1:160 ...
• Selective advantage of mutant stem cells in clonal hematopoiesis occurs by attenuating the deleterious effects of inflammation and aging

  Niels Asger Jakobsen, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-CD10-BV605 (1:40, Biolegend, clone HI10a), anti-CD117-BV785 (1:40 ...